BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20943766)

  • 1. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury.
    Yuan L; Wu MJ; Sun HY; Xiong J; Zhang Y; Liu CY; Fu LL; Liu DM; Liu HQ; Mei CL
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F207-18. PubMed ID: 20943766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.
    Morigi M; Introna M; Imberti B; Corna D; Abbate M; Rota C; Rottoli D; Benigni A; Perico N; Zoja C; Rambaldi A; Remuzzi A; Remuzzi G
    Stem Cells; 2008 Aug; 26(8):2075-82. PubMed ID: 18499895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-1 sustains stem cell mediated renal repair.
    Imberti B; Morigi M; Tomasoni S; Rota C; Corna D; Longaretti L; Rottoli D; Valsecchi F; Benigni A; Wang J; Abbate M; Zoja C; Remuzzi G
    J Am Soc Nephrol; 2007 Nov; 18(11):2921-8. PubMed ID: 17942965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.
    Tögel F; Weiss K; Yang Y; Hu Z; Zhang P; Westenfelder C
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1626-35. PubMed ID: 17213465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection.
    Eliopoulos N; Zhao J; Bouchentouf M; Forner K; Birman E; Yuan S; Boivin MN; Martineau D
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1288-98. PubMed ID: 20844023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.
    Morigi M; Rota C; Montemurro T; Montelatici E; Lo Cicero V; Imberti B; Abbate M; Zoja C; Cassis P; Longaretti L; Rebulla P; Introna M; Capelli C; Benigni A; Remuzzi G; Lazzari L
    Stem Cells; 2010 Mar; 28(3):513-22. PubMed ID: 20049901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
    Deuse T; Peter C; Fedak PW; Doyle T; Reichenspurner H; Zimmermann WH; Eschenhagen T; Stein W; Wu JC; Robbins RC; Schrepfer S
    Circulation; 2009 Sep; 120(11 Suppl):S247-54. PubMed ID: 19752375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions.
    Luo J; Zhao X; Tan Z; Su Z; Meng F; Zhang M
    Cytotherapy; 2013 Jun; 15(6):649-62. PubMed ID: 23415919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.
    Gatti S; Bruno S; Deregibus MC; Sordi A; Cantaluppi V; Tetta C; Camussi G
    Nephrol Dial Transplant; 2011 May; 26(5):1474-83. PubMed ID: 21324974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats.
    Kim JH; Park DJ; Yun JC; Jung MH; Yeo HD; Kim HJ; Kim DW; Yang JI; Lee GW; Jeong SH; Roh GS; Chang SH
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1141-50. PubMed ID: 22205231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal vascular endothelial growth factor in neonatal obstructive nephropathy. II. Exogenous VEGF.
    Burt LE; Forbes MS; Thornhill BA; Kiley SC; Minor JJ; Chevalier RL
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F168-74. PubMed ID: 16788139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC).
    Schichor C; Birnbaum T; Etminan N; Schnell O; Grau S; Miebach S; Aboody K; Padovan C; Straube A; Tonn JC; Goldbrunner R
    Exp Neurol; 2006 Jun; 199(2):301-10. PubMed ID: 16574102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury.
    Peng X; Xu H; Zhou Y; Wang B; Yan Y; Zhang X; Wang M; Gao S; Zhu W; Xu W; Qian H
    Exp Biol Med (Maywood); 2013 Aug; 238(8):960-70. PubMed ID: 23970411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cells protect against acute tubular injury via an endocrine effect.
    Bi B; Schmitt R; Israilova M; Nishio H; Cantley LG
    J Am Soc Nephrol; 2007 Sep; 18(9):2486-96. PubMed ID: 17656474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
    Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
    Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.
    Tögel F; Hu Z; Weiss K; Isaac J; Lange C; Westenfelder C
    Am J Physiol Renal Physiol; 2005 Jul; 289(1):F31-42. PubMed ID: 15713913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia.
    Toyama K; Honmou O; Harada K; Suzuki J; Houkin K; Hamada H; Kocsis JD
    Exp Neurol; 2009 Mar; 216(1):47-55. PubMed ID: 19094989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF improves survival of mesenchymal stem cells in infarcted hearts.
    Pons J; Huang Y; Arakawa-Hoyt J; Washko D; Takagawa J; Ye J; Grossman W; Su H
    Biochem Biophys Res Commun; 2008 Nov; 376(2):419-22. PubMed ID: 18789891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.
    Li S; Basnakian A; Bhatt R; Megyesi J; Gokden N; Shah SV; Portilla D
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F990-8. PubMed ID: 15280156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury.
    Shi H; Patschan D; Dietz GP; Bähr M; Plotkin M; Goligorsky MS
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F229-35. PubMed ID: 18003856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.